Bacterial Toxin Suspected in Rise of Under-50s Bowel Cancer

MPs on the Commons science and technology committee heard that early-life exposure to a bacterial toxin is a leading suspect in the rise of bowel cancer among people under 50, according to The Guardian.
The toxin is colibactin, which is produced by some variants of E. coli, a common type of bacteria that lives in the gut. Colibactin was identified last year as a potential driver of early-onset colorectal cancer, the medical term for bowel cancer that appears at a younger age.
Dr Karl Smith-Byrne told the committee that colibactin is "probably the leading explanation at the moment" for the rise in early-onset bowel cancer. He said that known risk factors such as obesity, smoking and alcohol can explain only about half of diagnosed colorectal cancer cases.
The committee also heard that mutations, which are changes in DNA, caused by colibactin were three times more common in tumours from people under 40 than in tumours from people over 70.
Prof Elio Riboli told the committee that colibactin is essentially found in people born after 1960.
The wider picture is one of growth. Cases of early-onset bowel cancer have doubled in many countries over the past two decades. Bowel cancer is the third most common cancer in the world, accounting for about one in 10 of all cases.


